Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

计划入组 34 人 · 首次发布于 2018 年 10 月 17 日

Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid Tumors

计划入组 12 人 · 首次发布于 2020 年 8 月 25 日

Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers

计划入组 29 人 · 首次发布于 2018 年 5 月 3 日

NY-ESO-1/LAGE-1A TCR-T cell therapy(Anocca AB)

NY-ESO-1 vaccine

NY-ESO-1 peptide vaccine

NHI-1

United States

Emotional Brain NY Inc.

Netherlands

Central Homecare Supplies NY, LLC

United States

Medigene Advances TCR-T Therapies with FDA Clearance and Strategic Partnerships

FDA Clears IND for Medigene's TCR-T Therapy MDG1015 in Advanced Solid Tumors

Medigene AG Refocuses Strategy on TCR-Guided Therapies, Pauses MDG1015 Trial